CN Patent

CN112569210B — 一种吸入用马昔腾坦溶液及其制备方法

Assigned to Beijing Increase Innovative Drug Co ltd · Expires 2023-09-15 · 3y expired

What this patent protects

本发明涉及一种吸入用马昔腾坦溶液及其制备方法，该吸入溶液包含活性成分马昔腾坦、稳定剂、等渗调节剂、pH值调节剂和溶剂；本发明吸入用马昔腾坦溶液单剂量规格为2ml，计量准确、疗效好；具有不含防腐剂，质量稳定，副反应少等优点。

USPTO Abstract

本发明涉及一种吸入用马昔腾坦溶液及其制备方法，该吸入溶液包含活性成分马昔腾坦、稳定剂、等渗调节剂、pH值调节剂和溶剂；本发明吸入用马昔腾坦溶液单剂量规格为2ml，计量准确、疗效好；具有不含防腐剂，质量稳定，副反应少等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN112569210B
Jurisdiction
CN
Classification
—
Expires
2023-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Increase Innovative Drug Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.